Highlighting Strategy for Selecting the Right ADC Combination Partner & Exploring Results From Preclinical & Clinical Studies
- Exploring clinical-stage trial design and results for Nectin-4 ADC-PD1 combinations
- Laying out rationale for CDH17 and B7H3 ADC combination partner selection
- Assessing emerging preclinical results from CDH17 and B7H3 ADC combination investigation compared to monotherapies